Large-scale analysis of single nucleotide polymorphisms (SNPs) allow genes that underlie complex disease to be identified. STAB VIDA offers genotyping methods that are high throughput, accurate and cheap for gaining full access to the abundant genetic variation of organisms. Whole genome approaches using single nucleotide polymorphism (SNP) markers have the potential to transform complex disease genetics and expedite pharmacogenetics research. Our current technology platforms are able to deliver throughputs in excess of 100 000 genotypes per day, with an accuracy of >99%, at a cost of 20–30 cents per genotype. DNA template requirements are minimised such that hundreds of thousands of SNPs can be interrogated using a relatively small amount of genomic DNA.
























